1. Home
  2. PMTS vs ELDN Comparison

PMTS vs ELDN Comparison

Compare PMTS & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$13.89

Market Cap

152.4M

Sector

Finance

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.00

Market Cap

208.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMTS
ELDN
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.4M
208.6M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
PMTS
ELDN
Price
$13.89
$3.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$27.67
$8.50
AVG Volume (30 Days)
73.8K
1.1M
Earning Date
03-05-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.27
EPS
1.25
N/A
Revenue
$312,189,000.00
N/A
Revenue This Year
$9.09
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$11.11
N/A
Revenue Growth
12.27
N/A
52 Week Low
$10.81
$1.35
52 Week High
$30.51
$4.60

Technical Indicators

Market Signals
Indicator
PMTS
ELDN
Relative Strength Index (RSI) 49.34 66.95
Support Level $12.26 $2.91
Resistance Level $16.38 $3.21
Average True Range (ATR) 1.08 0.21
MACD 0.01 0.01
Stochastic Oscillator 32.78 76.03

Price Performance

Historical Comparison
PMTS
ELDN

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: